T1	Participants 70 117	irritability in children with autistic disorder
T2	Participants 187 211	hyperglutamatergic state
T3	Participants 277 295	autistic disorders
T4	Participants 547 672	adjunctive to risperidone in the treatment of irritability in autistic children who were not optimally responding to previous
T5	Participants 673 684	medications
T6	Participants 819 996	male and female outpatients aged 5-12 years with a diagnosis of autistic disorder based on the DSM-IV-TR criteria and a score of ≥12 on the Aberrant Behavior Checklist-Community
T7	Participants 997 1096	(ABC-C) irritability subscale who had discontinued other medications because of a lack of efficacy.
T8	Participants 1661 1707	Forty-nine patients were enrolled in the study
